Usage of antiplatelet and anticoagulant agents in ischemic cardiomyopathy
Satoh, S.
Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 9): 423-427
2011
ISSN/ISBN: 0047-1852 PMID: 22724241 Document Number: 652773
Document emailed within 1 workday
Related Documents
Ishikawa, K. 2003: Anticoagulant, antiplatelet agents Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 4): 647-653Hegge, K.A. 2009: Antiplatelet agents for prevention of recurrent ischemic stroke South Dakota Medicine: the Journal of the South Dakota State Medical Association 62(1): 15-17
Melandri, G.; Semprini, F.; Cervi, V.; Candiotti, N.; Branzi, A. 1994: Chronic ischemic cardiopathy: antiplatelet agents and anticoagulants, new protocols for prevention and treatment Cardiologia 39(12 Suppl. 1): 347-352
Wynn, R.L. 2012: New antiplatelet and anticoagulant drugs General Dentistry 60(1): 8-11
Yamamoto, K. 2010: Anticoagulant or antiplatelet drugs and anesthesia Masui. Japanese Journal of Anesthesiology 59(9): 1160-1165
Capodanno, D.; Angiolillo, D.J.; Tamburino, C. 2011: Antiplatelet and anticoagulant therapy in elderly patients Giornale Italiano di Cardiologia 12(3): 186-197
Matsuoka, T.; Inoue, K.; Mizuno, K.; Kita, Y.; Nakanishi, S.; Asai, S.; Taoka, R.; Soda, T.; Terai, A. 2012: Heparin as bridging anticoagulant and antiplatelet therapy during the perioperative period Hinyokika Kiyo. Acta Urologica Japonica 58(5): 223-226
Udekwu, P.; Roy, S.; Stiles, A.; Dibbert, A.; Nguyen, M.; Rice, V. 2019: Impact of Anticoagulant and Antiplatelet use on Outcomes in Blunt Chest Injury American Surgeon 85(8): 871-876
Marchant, B.G.; Timmis, A.D. 1993: Benefits and risks of thrombolytic, anticoagulant and antiplatelet therapies in atrial fibrillation British Journal of Hospital Medicine 49(3): 186-190
Komissarenko, I.A. 2016: Erosive-Ulcerative Complications of Antiplatelet And/Or Anticoagulant Therapy in Elderly Patients Eksperimental'naia i Klinicheskaia Gastroenterologiia 6: 3-8
Masuda, Y. 2000: Differential diagnosis of idiopathic cardiomyopathy from ischemic cardiomyopathy and hypertensive heart disease using non-invasive methods Nihon Rinsho. Japanese Journal of Clinical Medicine 58(1): 218-222
Tian, Y.; Liu, X.; Shi, R.; Liu, Y.; Wu, Q.; Zhang, X. 2000: Radionuclide techniques for evaluating dilated cardiomyopathy and ischemic cardiomyopathy Chinese Medical Journal 113(5): 392-395
Krittayaphong, R.; Boonyasirinant, T.; Saiviroonporn, P.; Udompunturak, S. 2011: Late gadolinium enhancement from cardiac magnetic resonance in ischemic and non-ischemic cardiomyopathy Journal of the Medical Association of Thailand 94(Suppl 1): S33-S38
Gomes, O.M. 1982: Antiplatelet agents: how much? which one? for whom? Arquivos Brasileiros de Cardiologia 38(1): 1-2
Coccheri, S. 2013: New antiplatelet agents: are we better off now than we were with aspirin? Clinical Advances in Hematology and Oncology: H&o 11(12): 787-790
De Caterina, R.; Blanco, A. 1992: Nitrates as antiplatelet agents Sangre 37(1): 31-38
Wongchareon, W.; Phrommintikul, A.; Kanjanavanit, R.; Kuanprasert, S.; Sukonthasarn, A. 2005: A predictive model for distinguishing ischemic from non-ischemic cardiomyopathy Journal of the Medical Association of Thailand 88(11): 1689-1696
Bochenek, A.; Wilczyński, M.ła. 2006: Antiplatelet agents--problem for cardiac surgeon Kardiologia Polska 64(11): 1329-1331
De Gautard, G.; Perrier, A. 2014: Antiplatelet agents in secondary prevention of stroke Revue Medicale Suisse 10(446): 1902 1904-7
Griguer, R.P.; Brochier, M.; Raynaud, R. 1973: The place of fibrinolytic and antiplatelet-aggregation agents in therapy Annales de Cardiologie et d'Angeiologie 22(6): 461-472